Acceleron Pharma climbs on 1st day of trading


Save Story
Leer en espaƱol

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) - Shares of Acceleron Pharma are surging after the drug developer said its initial public offering priced at the high end of estimates.

Acceleron's IPO of 5.6 million shares priced at $15 per share, bringing it $83.7 million before expenses and underwriting discounts. The Cambridge, Mass., had expected to sell 4.7 million shares for $13 to $15 each.

The underwriters of the IPO will have the option to buy another 837,000 shares.

Acceleron Pharma Inc. shares advanced $5.10, or 34 percent, to $20.10 while the broader markets were down.

The stock is listed on the Nasdaq Global Market under the symbol "XLRN."

Separately, Celgene Corp. will buy 666,667 shares for $15 each, giving Acceleron another $10 million. The companies are studying two drugs together.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Most recent Business stories

Related topics

Business

STAY IN THE KNOW

Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

KSL Weather Forecast